Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Daiichi Sankyo-Merck's patritumab deruxtecan receive FDA approval by December 31, 2024?  | Binary | 4 | 3 months ago | ||
Will Daiichi Sankyo-Merck's patritumab deruxtecan receive EMA approval by March 31, 2025? | Binary | 4 | 3 months ago | ||
Will Daiichi Sankyo's stock price increase by 10% or more by December 31, 2024? | Binary | 3 | 3 months ago | ||
What will be the market share of patritumab deruxtecan in NSCLC treatments by December 31, 2025? | Categorical | 2 | 3 months ago | ||
How many new targeted oncology drugs will Daiichi Sankyo get approved by December 31, 2025? | Categorical | 2 | 3 months ago | ||
What will be the total revenue generated by patritumab deruxtecan by December 31, 2025? | Categorical | 2 | 3 months ago |